Literature DB >> 16572527

DEFB-1 genetic polymorphism screening in HIV-1 positive pregnant women and their children.

Ludovica Segat1, Michele Milanese, Michele Boniotto, Sergio Crovella, Maria Bernardon, Monica Costantini, Salvatore Alberico.   

Abstract

OBJECTIVE: In our study we evaluated the frequency of three SNPs (-52 G/A, -44 C/G; -20 G/A) in the 5' UTR of DEFB-1 gene, in a cohort of 130 HIV-1 infected mothers and their children, collected by the Italian group SIGO in Obstetrics and Gynecology.
METHODS: The three SNPs (-52 G/A, -44 C/G; -20 G/A) in the 5' UTR of DEFB-1 gene were genotyped by direct sequencing of PCR products.
RESULTS: The C allele at position -44 was shown to be significantly different in both HIV-1 positive mothers and their children when compared to the healthy controls. The odds ratio for -44 C allele in children born to HIV-1 infected mothers is 7.09 (confidence interval 3.38-15.3) while the odds ratio for this allele in HIV-1 infected mothers is 6.42 (confidence interval 3.14-13.4).
CONCLUSIONS: Our results evidence a high frequency of the -44 CC allele in HIV-1 infected mothers and their children with augmented potential risk of maternal fetal transmission. This potential vertical transmission risk has been successfully prevented by antiretroviral drug treatment and cesarian section of the HIV-1 positive mothers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572527     DOI: 10.1080/14767050500381123

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  12 in total

1.  A case of bilateral endophthalmitis and carriage of beta-defensin 1 44CC genotype.

Authors:  James Carter; Amanda J Churchill; Chris Gorman; Richard Haynes
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

2.  DEFB1 polymorphisms and HIV-1 mother-to-child transmission in Zambian population.

Authors:  Luisa Zupin; Vania Polesello; Ludovica Segat; Anselmo Jiro Kamada; Louise Kuhn; Sergio Crovella
Journal:  J Matern Fetal Neonatal Med       Date:  2018-03-20

Review 3.  Cathelicidins and defensins antimicrobial host defense peptides in the treatment of TB and HIV: Pharmacogenomic and nanomedicine approaches towards improved therapeutic outcomes.

Authors:  Prince N Dlozi; Angelina Gladchuk; Rustin D Crutchley; Nicole Keuler; Renier Coetzee; Admire Dube
Journal:  Biomed Pharmacother       Date:  2022-05-28       Impact factor: 7.419

4.  Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals.

Authors:  Wildeman Zapata; Benigno Rodriguez; Jan Weber; Hernando Estrada; Miguel E Quiñones-Mateu; Peter A Zimermman; Michael M Lederman; Maria T Rugeles
Journal:  Curr HIV Res       Date:  2008-11       Impact factor: 1.581

Review 5.  Susceptibility to infectious diseases based on antimicrobial peptide production.

Authors:  Bruno Rivas-Santiago; Carmen J Serrano; J Antonio Enciso-Moreno
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

6.  Variation in human β-defensin genes: new insights from a multi-population study.

Authors:  R K Mehlotra; P A Zimmerman; A Weinberg; R J Jurevic
Journal:  Int J Immunogenet       Date:  2012-11-29       Impact factor: 1.466

Review 7.  An update on the genetics of atopic dermatitis: scratching the surface in 2009.

Authors:  Kathleen C Barnes
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

8.  A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans.

Authors:  Jeffrey Tomalka; Sandhya Ganesan; Elaheh Azodi; Krupen Patel; Parth Majmudar; Brian A Hall; Katherine A Fitzgerald; Amy G Hise
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

9.  Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytes.

Authors:  Andrea A Kalus; L Page Fredericks; Beth M Hacker; Henrik Dommisch; Richard B Presland; Janet R Kimball; Beverly A Dale
Journal:  BMC Oral Health       Date:  2009-08-27       Impact factor: 2.757

10.  Clinical application of human β-defensin and CD14 gene polymorphism in evaluating the status of chronic inflammation.

Authors:  Wings T Y Loo; Lan-jun Bai; Chang-bin Fan; Yuan Yue; Yi-ding Dou; Min Wang; Hao Liang; Mary N B Cheung; Louis W C Chow; Jin-le Li; Ye Tian; Liu Qing
Journal:  J Transl Med       Date:  2012-09-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.